Tramadol Drug Market - By Dosage Form (Tablet, Capsule, Liquid, Suspension), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Global Forecast, 2023-2032
Published Date: July - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationTramadol Drug Market Size
Tramadol Drug Market size was valued to be USD 4.5 billion in 2022 and is expected to reach USD 8.6 billion in 2032, growing at a CAGR of 6.8% from 2023 to 2032. The market's significant growth is primarily driven by the rising prevalence of pain disorders such as arthritis, neuropathy, or fibromyalgia.
For instance, according to the Good Body stats, at least 10% of the world’s population is affected by chronic pain, and it has been estimated that 1 in every 5 adults suffer from pain and some acute pains which are undiagnosed till it becomes chronic. Similarly, increase in geriatric population coupled with rise in lower back pain which requires surgery, therapy, and pain management drugs is also boosting the market. Moreover, growing healthcare infrastructure in emerging markets, rising awareness pertaining to pain management, and increasing R&D activities are expected to fuel the market’s growth during the forecast period.
Tramadol is a drug used to relieve moderate to severe pain. It belongs to a class of drugs known as opioid analgesics or opioids. It works by binding to opioid receptors in the brain and spinal cord, which helps to alter the way the body perceives and responds to pain. It is used to manage various types of pain, such as post-surgical pain, chronic pain associated with conditions like osteoarthritis or neuropathy, and pain from injuries.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Tramadol Drug Market Size in 2022 | USD 4.5 Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 6.8% |
| 2032 Value Projection | USD 8.6 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 120 |
| Tables, Charts & Figures | 206 |
| Segments covered | Dosage Form, Route of Administration, Distribution Channel, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
COVID-19 Impact
The COVID-19 pandemic had a moderately positive impact on tramadol drug market. Due to safety restrictions enforced by governments, many clinics and pain services were no longer open for public. However, the increased adoption of telemedicine and virtual consultations during the pandemic had led to greater awareness and education about various treatment options, including pain management. As many people worked from home, ergonomic challenges and musculoskeletal issues became more common. This resulted in increased pain complaints and the need for pain management, potentially involving tramadol.
Also, the pandemic led to increased stress, anxiety, and mental health issues for many individuals, which exacerbated pain conditions. Few COVID-19 patients experienced lingering symptoms, such as body aches and pain, which required tramadol to reduce the symptoms. Furthermore, many elective surgeries and medical procedures were postponed to conserve healthcare resources and reduce the risk of transmission. As a result, some patients experienced prolonged pain and required tramadol for pain relief. Thus, the aforementioned factors contributed to the expansion of market.
Tramadol Drug Market Driving Factors
The major factor driving the growth of the market is the increasing prevalence of pain and pain disorders globally.For instance, according to Centers for Disease Control and Prevention (CDC), in the U.S. adults, about 58.5 million people had doctor-diagnosed arthritis and by 2040, an estimated 78.4 million adults will have doctor-diagnosed arthritis. Therefore, pain can have substantial impacts on bodily function and limitations on various activities, affecting various physiological and psychological processes. It causes hyperalgesia, sleep disturbance, immune system suppression, and muscle tension. The complications can vary depending on the age of the affected individual.
Tramadol Drug Market Restraint
While tramadol plays a crucial role in pain management, the various side effects associated with the drug can impact drug uptake and market dynamics. Though these side effects can vary in severity and occurrence among individuals, some common ones include nausea, vomiting, dizziness and drowsiness, that can impair a person's ability to concentrate and perceive the surrounding. Headaches, dry mouth, and constipation are relatively common whereas, skin reactions, including itching and rashes, are possible side effects but less common.
Moreover, tramadol, like other opioids, can slow down breathing in some cases, particularly when taken in high doses or combined with other central nervous system depressants, such as alcohol and seizures. Thus, such factors may hamper the market progress.
Tramadol Drug Market Analysis
When it comes to taking tramadol, you have a few options depending on how you prefer to swallow your medication. You can choose from tablets, capsules, liquids, or suspensions. Among these, tablets are the most popular and convenient form. They're like tiny, solid pills that are easy to gulp down. This makes them the go-to choice for those who need to take tramadol regularly for pain relief. Tablets also have the advantage of being precise. Each one contains an exact amount of tramadol, so you can be sure you're getting the right dose every time. This is especially important when managing chronic pain, as it helps ensure you get the amount you need for effective pain relief.
Moreover, tablets are relatively easy for patients to manage and adhere to their prescribed treatment regimen. Patients can easily keep track of when they need to take their medication, which is essential for effective pain management. Therefore, due to their familiarity, ease of use, and ease of storage, tablets will contribute to expand the market expansion.
When it comes to taking tramadol, you have a few options based on how you want to take it. The most popular choice is by mouth, which is also called the oral route. Back in 2022, people used the oral route the most, making it the leader in the tramadol market. Taking medication by mouth is easy and familiar for many people. You can do it yourself without much hassle. Plus, it's not invasive, which means it won't involve needles or anything like that. This makes it a good option for people who are comfortable taking pills or capsules. Another benefit of taking tramadol by mouth is that you can adjust the dose to fit your needs. It comes in different forms, like pills that work right away or extended-release capsules that keep working over time. This flexibility helps doctors find the best pain management plan for each person. And because tramadol gets absorbed into your body well through your digestive system, taking it by mouth is a reliable way to get the relief you need.
When it comes to getting Tramadol, your options depend on where you go. You can head to a hospital pharmacy, a regular pharmacy, or even order it online. Hospital pharmacies are like the VIPs of the Tramadol world. They're expected to bring in a whopping $5 billion by 2032! That's because they're super important for getting the drug to patients in hospitals. You see, hospitals are where people go when they need help with serious stuff like accidents, surgery, and all sorts of painful conditions. And guess what? Tramadol is often just what the doctor ordered for pain relief in these cases. Plus, hospitals have all kinds of patients from young to old, so there's a good chance you'll find Tramadol there when you need it.
In 2022, the North American tramadol drug market held the largest share of 38.6% and is anticipated to show considerable growth during the analysis period. The region has a relatively high prevalence of pain conditions, including acute and chronic pain resulting from various factors such as surgical procedures, injuries, and medical conditions. For instance, according to Centers for Disease Control and Prevention (CDC), nearly 20.9% of U.S. adults experienced chronic pain, and 6.9% experienced high-impact chronic pain. Thus, the demand for pain management medications like tramadol is driven by the significant patient population in need of pain relief.
Additionally. The market is being driven by favourable initiatives and aids from governments as well as significant research & development expenditures in the region. Further, the region's prominence on patient-focused care, along with the availability of tramadol, specialized medical centers, and awareness, further drives the demand for market in the region.
Tramadol Drug Market Share
The top players in the global tramadol drug market are
- Zydus Cadila
- Purdue Pharma
- Mankind Pharma Ltd
- Mundipharma
- Amneal Pharmaceuticals
- Par Pharmaceuticals
- Vertical Pharmaceuticals
- Grunenthal Group
- Nippon Shinyaku Co., Ltd.
These companies are implementing several strategies such as collaborations, acquisitions, partnerships, mergers, and product launches to maintain a competitive edge in the industry.
Tramadol Drug Market Industry News
- In September 2020, Athena Biosciences received the U.S. FDA approval for its Qdolo (tramadol) oral solution. The solution is utilized for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. This enabled company to add value to its business segment and expand the company’s revenue.
- In November 2018, Cipla acquired U.S.-based Avenue Therapeutics. The acquisition gave Cipla access to specialty drug tramadol delivered intravenously (IV) to manage post-operative pain. This increased the Cipla’s product portfolio.
The tramadol drug market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Dosage Form
- Tablet
- Capsule
- Liquid
- Suspension
- Other dosage forms
By Route of Administration
- Oral
- Parenteral
- Other routes of administration
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- Rest of Asia Pacific
- Latin Americ
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of Middle East & Africa
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy